Pharmacology, Toxicology and Pharmaceutical Science
Microflora
66%
Gene Delivery
47%
Cystic Fibrosis
37%
Pseudomonas Infection
33%
Plasmid DNA
33%
Infection
33%
Model Selection
33%
Neurologic Disease
33%
Clinical Trial
33%
Palmitoyl Protein Thioesterase
22%
Pseudomonadales
19%
Green Fluorescent Protein
19%
Plasmid Vector
16%
Disease Exacerbation
16%
Route of Administration
16%
Bacterial DNA
14%
RNA 16S
11%
Neuronal Ceroid Lipofuscinosis
11%
Lysosome Enzyme
11%
Cystic Fibrosis Transmembrane Conductance Regulator
11%
Colistimethate
10%
Diseases
9%
Microorganism
9%
Inflammation
8%
Normal Human
8%
Messenger RNA
7%
Agar
7%
Polyethyleneimine
7%
Enzyme Deficiency
5%
Storage Disease
5%
Glycopyrronium
5%
Cholinergic Receptor Blocking Agent
5%
Biochemistry, Genetics and Molecular Biology
Gene Transfer Agent
75%
Cystic Fibrosis
75%
Gene Therapy
46%
Clinical Trial
41%
Cationic Lipid
41%
Nonviral Gene Delivery System
41%
Messenger RNA
34%
Reporter Gene
33%
Luciferase
33%
Pseudomonadales
19%
Recombinant Protein
16%
Macrophage
16%
Transfection
16%
Promoter Region
16%
Plasmid Vector
16%
Cystic Fibrosis Transmembrane Conductance Regulator
14%
Animal Models
9%
Polyethyleneimine
9%
Nebulization
8%
Gene Expression
8%
Medicine and Dentistry
Lung
100%
Infection
66%
Pseudomonas Infection
33%
Exhaled Breath Condensate
33%
Visna Virus
33%
Virus
15%
Agar
7%
Colistimethate
7%
Bacterial DNA
7%
Bronchoalveolar Lavage Fluid
6%
Trachea
6%
Intratracheal Drug Administration
6%
Infantile Neuronal Ceroid Lipofuscinosis
5%
Enzyme Deficiency
5%
